• Incorporating Indirect Costs into a Cost-Benefit Analysis of Laparoscopic Adjustable Gastric Banding

    Mar 1, 2012, 00:00

  • Prospective Observational Studies to Assess Comparative Effectiveness- The ISPOR Good Research Practices Task Force Report

    Mar 1, 2012, 00:00

  • Cost-Effectiveness of Adjuvant FOLFOX Therapy for Stage III Colon Cancer in Japan Based on the MOSAIC Trial

    Mar 1, 2012, 00:00

  • Resource Use, Costs, and Utility Estimates for Patients with Cystic Fibrosis with Mild Impairment in Lung Function- Analysis of Data Collected Alongside a 48-Week Multicenter Clinical Trial

    Mar 1, 2012, 00:00

  • Patient Access to New Cancer Drugs in the United States and Australia

    Mar 1, 2012, 00:00

  • Cost-Effectiveness Evaluation in Sweden of Escitalopram Compared with Venlafaxine Extended-Release as First-Line Treatment in Major Depressive Disorder

    Mar 1, 2012, 00:00

  • Learning Effects in Time Trade-Off Based Valuation of EQ-5D Health States

    Mar 1, 2012, 00:00

  • Health-Related Quality of Life Measurement in Children and Adolescents in Ibero-American Countries, 2000 to 2010

    Mar 1, 2012, 00:00

  • Estimating Preference-Based Single Index Measures for Dementia Using DEMQOL and DEMQOL-Proxy

    Mar 1, 2012, 00:00

  • Editorial Board

    Mar 1, 2012, 00:00

  • Quality-Adjusted Life Expectancies in Patients with Rheumatoid Arthritis—Comparison of Index Scores from EQ-5D, 15D, and SF-6D

    Mar 1, 2012, 00:00

  • Lifetime Cost-Effectiveness of Skin Cancer Prevention through Promotion of Daily Sunscreen Use

    Mar 1, 2012, 00:00

  • Comparative Effectiveness, Cost, and Utilization of Radical Prostatectomy among Young Men within Managed Care Insurance Plans

    Mar 1, 2012, 00:00

  • Comparative Health-Care Cost Advantage of Ipratropium over Tiotropium in COPD Patients

    Mar 1, 2012, 00:00

  • Cost-Effectiveness of Different Strategies for Selecting and Treating Individuals at Increased Risk of Osteoporosis or Osteopenia- A Systematic Review

    Mar 1, 2012, 00:00

  • Conducting Comparative Effectiveness Research on Medications- The Views of a Practicing Epidemiologist from the Other Washington

    Mar 1, 2012, 00:00

  • Antihypertensive Drugs- A Perspective on Pharmaceutical Price Erosion and Its Impact on Cost-Effectiveness

    Mar 1, 2012, 00:00

  • Innovation and the Burden of Disease- Retrospective Observational Study of New and Emerging Health Technologies Reported by the EuroScan Network from 2000 to 2009

    Mar 1, 2012, 00:00

  • A Review of the Cost of Atrial Fibrillation

    Mar 1, 2012, 00:00

  • Improving the Measurement of QALYs in Dementia- Developing Patient- and Carer-Reported Health State Classification Systems Using Rasch Analysis

    Mar 1, 2012, 00:00

  • Patient Access to New Cancer Drugs in the United States and Australia—Reply to Letter to the Editor by Dr. Wonder

    Mar 1, 2012, 00:00

  • Can Observational Studies Approximate RCTs?

    Mar 1, 2012, 00:00

  • Pharmaceutical Cost-Containment Policies and Sustainability- Recent Irish Experience

    Mar 1, 2012, 00:00

  • Informing Shared Decisions about Advance Directives for Patients with Severe Chronic Obstructive Pulmonary Disease- A Modeling Approach

    Mar 1, 2012, 00:00

  • Table of Contents

    Mar 1, 2012, 00:00

  • Comparison of FACT- and EQ-5D–Based Utility Scores in Cancer

    Mar 1, 2012, 00:00

  • Copyright/Subscription

    Mar 1, 2012, 00:00

  • ISPOR Code of Ethics

    Jan 1, 2012, 00:00

  • Eliciting Public Preference for Health-Care Resource Allocation in South Korea

    Jan 1, 2012, 00:00

  • Copyright/Subscription

    Jan 1, 2012, 00:00

  • Development of a Composite Questionnaire, the Valuation of Lost Productivity, to Value Productivity Losses- Application in Rheumatoid Arthritis

    Jan 1, 2012, 00:00

  • Impact of Secondary Cardiovascular Events on Health Status

    Jan 1, 2012, 00:00

  • Erratum

    Jan 1, 2012, 00:00

  • The Effects of Medication Supply on Hospitalizations and Health-Care Costs in Patients with Chronic Heart Failure

    Jan 1, 2012, 00:00

  • Extension of Kaplan-Meier Methods in Observational Studies with Time-Varying Treatment

    Jan 1, 2012, 00:00

  • Cost and Effectiveness Evaluation of Prophylactic HPV Vaccine in Developing Countries

    Jan 1, 2012, 00:00

  • Different Policy Outcomes of the New Drugs and Currently Listed Drugs under the Positive List System in South Korea

    Jan 1, 2012, 00:00

  • Copyright/Subscription

    Jan 1, 2012, 00:00

  • Direct Cost Analysis of Intensive Care Unit Stay in Four European Countries- Applying a Standardized Costing Methodology

    Jan 1, 2012, 00:00

  • Feasibility and Construct Validity of PROMIS and “Legacy” Instruments in an Academic Scleroderma Clinic

    Jan 1, 2012, 00:00

  • The Role of the Expected Value of Individualized Care in Cost-Effectiveness Analyses and Decision Making

    Jan 1, 2012, 00:00

  • Bridging the Gap in Pharmacoeconomics and Outcomes Research between Researchers, Policymakers, and Practitioners in the Asia-Pacific Region

    Jan 1, 2012, 00:00

  • Cost of Illness and Quality of Life of Patients with Rheumatoid Arthritis in South Korea

    Jan 1, 2012, 00:00

  • Table of Contents

    Jan 1, 2012, 00:00

  • Cost-Effectiveness of Nonpharmacologic, Nonsurgical Interventions for Hip and/or Knee Osteoarthritis- Systematic Review

    Jan 1, 2012, 00:00

  • 3rd Special Issue- Pharmacoeconomics Outcomes Research in Asia

    Jan 1, 2012, 00:00

  • Successful Implementation of a P&T-Approved Therapeutic Interchange Program of Angiotensin II Receptor Blockers in a Medical Center in Taiwan

    Jan 1, 2012, 00:00

  • Evidence to Inform Decision Makers in Thailand- A Cost-Effectiveness Analysis of Screening and Treatment Strategies for Postmenopausal Osteoporosis

    Jan 1, 2012, 00:00

  • Evidence-Based Prediction of Statin Use with Lipid-Panel Data from the National Health and Nutrition Examination Survey

    Jan 1, 2012, 00:00

  • Reviewer Acknowledgement

    Jan 1, 2012, 00:00

  • Clinical and Economic Outcomes Associated with Adjuvant Chemotherapy in Elderly Patients with Early Stage Operable Breast Cancer

    Jan 1, 2012, 00:00

  • Priority Symptoms in Advanced Breast Cancer- Development and Initial Validation of the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index (NFBSI-16)

    Jan 1, 2012, 00:00

  • The Cost-Effectiveness of Different Chemotherapy Strategies for Patients with Poor Prognosis Advanced Colorectal Cancer (MRC FOCUS)

    Jan 1, 2012, 00:00

  • Stated Preferences of Physicians and Chronic Pain Sufferers in the Use of Classic Strong Opioids

    Jan 1, 2012, 00:00

  • Further Validation of the Uterine Fibroid Symptom and Quality-of-Life Questionnaire

    Jan 1, 2012, 00:00

  • Modeling Cost-Effectiveness of Cervical Cancer Screening in Hungary

    Jan 1, 2012, 00:00

  • Health-Care Data Collecting, Sharing, and Using in Thailand, China Mainland, South Korea, Taiwan, Japan, and Malaysia

    Jan 1, 2012, 00:00

  • Cost-Effectiveness Analysis of Pneumococcal Conjugate Vaccine in Taiwan- A Transmission Dynamic Modeling Approach

    Jan 1, 2012, 00:00

  • Updating and Confirming an Industry-Sponsored Pharmacoeconomic Model- Comparing Two Antipsychotics in the Treatment of Schizophrenia

    Jan 1, 2012, 00:00

  • The Performance of a Value Set for the EQ-5D Based on Experienced Health States in Patients with Inflammatory Bowel Disease

    Jan 1, 2012, 00:00

  • Cost-Effectiveness of Switching Patients with Type 2 Diabetes from Insulin Glargine to Insulin Detemir in Chinese Setting- A Health Economic Model Based on the PREDICTIVE Study

    Jan 1, 2012, 00:00

  • Comparing Methods for Identifying Future High-Cost Mental Health Cases in Medicaid

    Jan 1, 2012, 00:00

  • Editorial Board

    Jan 1, 2012, 00:00

  • Modeling the Effects of H1N1 Influenza Vaccine Distribution in the United States

    Jan 1, 2012, 00:00

  • Impact of the Introduction of Government Use Licenses on the Drug Expenditure on Seven Medicines in Thailand

    Jan 1, 2012, 00:00

  • Health Utility Measured with EQ-5D in Thai Patients Undergoing Peritoneal Dialysis

    Jan 1, 2012, 00:00

  • Cost-Effectiveness Analysis for Antidepressants and Cognitive Behavioral Therapy for Major Depression in Thailand

    Jan 1, 2012, 00:00

  • Instructions for Authors

    Jan 1, 2012, 00:00

  • Antibiotic-Prescribing Practices of Primary Care Prescribers for Acute Diarrhea in New Delhi, India

    Jan 1, 2012, 00:00

  • Cost-Effectiveness of Maintenance Pemetrexed in Patients with Advanced Nonsquamous-Cell Lung Cancer from the Perspective of the Swiss Health Care System

    Jan 1, 2012, 00:00

  • The Burden of Illness for Patients with Viral Hepatitis C- Evidence from a National Survey in Japan

    Jan 1, 2012, 00:00

  • Quantifying the Impact of Drug Exposure Misclassification due to Restrictive Drug Coverage in Administrative Databases- A Simulation Cohort Study

    Jan 1, 2012, 00:00

  • Table of Contents

    Jan 1, 2012, 00:00

  • Guide for Authors

    Jan 1, 2012, 00:00

  • Economic Implications of the Dynamic Relationship between Antibiotic Use and Hospital-Acquired Infections

    Jan 1, 2012, 00:00

  • An Exploratory Study of Response Shift in Health-Related Quality of Life and Utility Assessment Among Patients with Osteoarthritis Undergoing Total Knee Replacement Surgery in a Tertiary Hospital in Singapore

    Jan 1, 2012, 00:00

  • Assessment of Pharmacoeconomic Evaluations Submitted for Reimbursement in Korea

    Jan 1, 2012, 00:00

  • Availability, Health-Care Costs, and Utilization Patterns of Biologics in Taiwan

    Jan 1, 2012, 00:00

  • Estimating an EQ-5D Value Set for Malaysia Using Time Trade-Off and Visual Analogue Scale Methods

    Jan 1, 2012, 00:00

  • A Multilevel Analysis of Regional and Individual Effects on Methadone Maintenance Treatment in Taiwan

    Jan 1, 2012, 00:00

  • Reviewing the Cost-Effectiveness of Endocrine Early Breast Cancer Therapies- Influence of Differences in Modeling Methods on Outcomes

    Jan 1, 2012, 00:00

  • Delisting Policy Reform in South Korea- Failed or Policy Change?

    Jan 1, 2012, 00:00

  • A Review of Generic Preference-Based Measures of Health-Related Quality of Life in Visual Disorders

    Jan 1, 2012, 00:00

  • Cost-Effectiveness of Various Tuberculosis Control Strategies in Thailand

    Jan 1, 2012, 00:00

  • Drug Reimbursement Decision-Making in Thailand, China, and South Korea

    Jan 1, 2012, 00:00

  • The MacNew Heart Disease Health-Related Quality of Life Questionnaire in Patients with Angina and Patients with Ischemic Heart Failure

    Jan 1, 2012, 00:00

  • National Drug Policies to Local Formulary Decisions in Thailand, China, and Australia- Drug Listing Changes and Opportunities

    Jan 1, 2012, 00:00

  • Editorial Board

    Jan 1, 2012, 00:00

  • Toward Identifying the Causes and Combinations of Causes Increasing the Risks of Nonadherence to Medical Regimens- Combined Results of Two German Self-Report Surveys

    Dec 1, 2011, 00:00

  • Structural Frameworks and Key Model Parameters in Cost-Effectiveness Analyses for Current and Future Treatments of Chronic Hepatitis C

    Dec 1, 2011, 00:00

  • Practical Implications of Differential Discounting of Costs and Health Effects in Cost-Effectiveness Analysis

    Dec 1, 2011, 00:00

  • Social Valuation of EQ-5D Health States- The Chilean Case

    Dec 1, 2011, 00:00

  • Cost-Effectiveness Analysis of a Universal Infant Immunization Program with Meningococcal C Conjugate Vaccine in Brazil

    Dec 1, 2011, 00:00

  • Prioritizing Pharmacogenetic Research- A Value of Information Analysis of CYP2D6 Testing to Guide Breast Cancer Treatment

    Dec 1, 2011, 00:00

  • Methods for Using Data Abstracted from Medical Charts to Impute Longitudinal Missing Data in a Clinical Trial

    Dec 1, 2011, 00:00

  • Content Validity—Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation- ISPOR PRO Good Research Practices Task Force Report- Part 2—Assessing Respondent Underst ...

    Dec 1, 2011, 00:00

  • Guide for Authors

    Dec 1, 2011, 00:00

  • The National Institute for Health and Clinical Excellence Single Technology Appraisal Process- Lessons from the First 4 Years

    Dec 1, 2011, 00:00

  • Assuring the Patient Centeredness of Patient-Reported Outcomes- Content Validity in Medical Product Development and Comparative Effectiveness Research

    Dec 1, 2011, 00:00

  • Some Cautions on the Use of Instrumental Variables Estimators in Outcomes Research- How Bias in Instrumental Variables Estimators Is Affected by Instrument Strength, Instrument Contamination, and Sample Size

    Dec 1, 2011, 00:00

  • Developing and Applying a Stochastic Dynamic Population Model for Chronic Obstructive Pulmonary Disease

    Dec 1, 2011, 00:00

  • Effect of Health-Related Quality-Of-Life Instrument and Quality-Adjusted Life Year Calculation Method on the Number of Life Years Gained in the Critical Care Setting

    Dec 1, 2011, 00:00

  • Elicitation of Informed General Population Health State Utility Values- A Review of the Literature

    Dec 1, 2011, 00:00

  • Economics of Switching to Second-Line Antiretroviral Therapy with Lopinavir/Ritonavir in Africa- Estimates Based on DART Trial Results and Costs for Uganda and Kenya

    Dec 1, 2011, 00:00

  • EQ-5D for the Assessment of Health-Related Quality of Life and Resource Allocation in Children- A Systematic Methodological Review

    Dec 1, 2011, 00:00

  • Content Validity—Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation- ISPOR PRO Good Research Practices Task Force Report- Part 1—Eliciting Concepts for a New ...

    Dec 1, 2011, 00:00

  • DRG-Based Hospital Payment Systems and Technological Innovation in 12 European Countries

    Dec 1, 2011, 00:00

  • Cost-Utility Analyses of Diagnostic Laboratory Tests- A Systematic Review

    Dec 1, 2011, 00:00

  • Cost-Effectiveness of Dasatinib and Nilotinib for Imatinib-Resistant or -Intolerant Chronic Phase Chronic Myeloid Leukemia

    Dec 1, 2011, 00:00

  • Editorial Board

    Dec 1, 2011, 00:00

  • Response Burden and Questionnaire Length- Is Shorter Better? A Review and Meta-analysis

    Dec 1, 2011, 00:00

  • When Evaluating Parameter Uncertainty Is Not Enough- The Case of Dasatinib and Nilotinib for Imatinib-Resistant Chronic Myeloid Leukemia

    Dec 1, 2011, 00:00

  • Copyright/Subscription

    Dec 1, 2011, 00:00

  • Cost-Effectiveness of the Introduction of a Pre-Erythrocytic Malaria Vaccine into the Expanded Program on Immunization in Sub-Saharan Africa- Analysis of Uncertainties Using a Stochastic Individual-Based Simulation Model of Plasmodium falci ...

    Dec 1, 2011, 00:00

  • Preferences for CT Colonography and Colonoscopy as Diagnostic Tests for Colorectal Cancer- A Discrete Choice Experiment

    Dec 1, 2011, 00:00

  • Reviewer Acknowledgment

    Dec 1, 2011, 00:00

  • Cost-Effectiveness of Lanthanum Carbonate versus Sevelamer Hydrochloride for the Treatment of Hyperphosphatemia in Patients with End-Stage Renal Disease- A US Payer Perspective

    Dec 1, 2011, 00:00

  • Development, Reliability, and Validity of a New Preference and Satisfaction Questionnaire

    Dec 1, 2011, 00:00

  • Estimating Population-Based Values for EQ-5D Health States in Thailand

    Dec 1, 2011, 00:00

  • Table of Contents

    Dec 1, 2011, 00:00

  • PHP68 Assessment of the NHS Hospitals' Productivity in the Regional Health Authority of Thessaly in Greece

    Nov 1, 2011, 00:00

  • PMH58 Donepezil Oral Disintegrating Versus Donepezil Standard Tablets on Objective Burden of Caregivers of NaÏve Patients with Alzheimer'S Disease

    Nov 1, 2011, 00:00

  • PCN100 A Cost–Utility Analysis of Degarelix in the Treatment of Advanced Hormone-Dependent Prostate Cancer in Scotland

    Nov 1, 2011, 00:00

  • PCV1 Explorative Analysis about the Appropriateness of a GPS Longitudinal Database on Evaluating Atypical Antipsychotics in Terms of Drugs Adverse Events

    Nov 1, 2011, 00:00

  • PRM3 Challenges to Obtain Real-Life Data in Observational Studies- What are the Solutions When the Patient is the Main Data Provider?

    Nov 1, 2011, 00:00

  • PHP85 A Systematic Review of Automated Dose Dispensing in Primary Health Care

    Nov 1, 2011, 00:00

  • PIH20 the Burden of Endometriosis- Costs and Quality of Life of Women with Endometriosis Treated in Referral Centres

    Nov 1, 2011, 00:00

  • TP2 Patrones De Tratamiento De La Leucemia Mieloide Crónica (Lmc) En Pacientes Resistentes O Intolerantes A Imatinib En Instituciones De Salud Pública En México

    Nov 1, 2011, 00:00

  • PIH26 Economic Evaluation of Dienogest for Endometriosis in the Context of Korea National Health insurance

    Nov 1, 2011, 00:00

  • HG1 Applying Frailty Model in Longitudinal Survivals of Chronic Diseases

    Nov 1, 2011, 00:00

  • PDB62 The Impact of Clinical Inertia in the Treatment of Type 2 Diabetes

    Nov 1, 2011, 00:00

  • PHP22 Use of Decision Modeling to Estimate the Negative Impact of Tobacco Use on Health Care Costs and Health Disparities in People Living with HIV

    Nov 1, 2011, 00:00

  • PCN8 Cost-Effectiveness Analysis of an Opioid in Combination with Gabapentin Versus Monotherapy for the Treatment of Neuropathic Pain

    Nov 1, 2011, 00:00

  • PIN1 Pharmacist Participation in Antiretroviral Drug Monitoring for the Prevention of Mother-to-Child Transmission of HIV at Warinchumrab Hospital, Ubonratchathani, Thailand

    Nov 1, 2011, 00:00

  • PHP102 Biosimilars- Pricing Reimbursement in Germany- Key Insights From Sickness Funds

    Nov 1, 2011, 00:00

  • PCN183 A Population-Based Registry for the Evaluation of New Treatment Options for Patients with Metastatic Renal Cell Carcinoma

    Nov 1, 2011, 00:00

  • PCN7 The Incidence and Outcome of Febrile Neutropenia in Different Chemotherapy Regimens for Cancer Patients in Belgium

    Nov 1, 2011, 00:00

  • PSU20 Estimating Preferences for Economic Evaluation in Patients with Localized Prostate Cancer

    Nov 1, 2011, 00:00

  • PND17 Treatment Experience, Burden, and Unmet Needs (Tribune) in Multiple Sclerosis Study- Excess Burden Due to Relapses

    Nov 1, 2011, 00:00

  • PRS19 Quality of Life and Economics of Asthma Control in France and Spain- Final Results of the EU-Coast Study

    Nov 1, 2011, 00:00

  • PUK3 COST-Effectiveness Of Anemia Treatment In Dialysis Patients In BRAZIL

    Nov 1, 2011, 00:00

  • PSU18 Cost-Utility Analysis of Laparoscopic Versus Open Surgery for Colorectal Cancer

    Nov 1, 2011, 00:00

  • PRM56 Differential Discounting- Questioning the Assumption of Healthcare Resource Fungibility Over Time

    Nov 1, 2011, 00:00

  • PHP118 Analysis of Pricing Reimbursement Approval Process for New Drugs in Korea Under Newly-Introduced HTA Environment (2007-2010)

    Nov 1, 2011, 00:00

  • PMD2 Clinical Decision Rules for Adults with Minor Head injury- A Systematic Review

    Nov 1, 2011, 00:00

  • PCN108 Economic Evaluation of Sunitinib Malate for the First-Line Treatment of Metastaric Renal Cell Carcinoma in the Chinese Health Care Setting

    Nov 1, 2011, 00:00

  • PCV104 Persistence in Hypertension Treatment with Olmesartan Medoxomil Versus Valsartan - Analysis of Real-Life Prescription Data in Germany

    Nov 1, 2011, 00:00

  • PMD31 Economic Evaluation of Primovist versus Extracellular Contrast in Imaging of Liver Metastases of Colorectal Origin

    Nov 1, 2011, 00:00

  • PRS72 How Much Would the Universal Uptake of Gold Recommendations for Italian COPD Patients Cost?

    Nov 1, 2011, 00:00

  • PMS63 New Developments in the Ankylosing Spondylitis Quality of Life (ASQOL) Scale

    Nov 1, 2011, 00:00

  • PSY27 Cost-Consequence Analysis Comparing Romiplostim to Rituximab in the Treatment of Adult Primary Immune Thrombocytopenia (Itp) in France

    Nov 1, 2011, 00:00

  • PCN78 Review of the Recent Pharmaceutical Additions to the Treatment of Colorectal Cancer

    Nov 1, 2011, 00:00

  • PUK5 Mixed Treatment Comparisons of Immunosuppressants Following Renal Transplant

    Nov 1, 2011, 00:00

  • PCV97 Cost-Effectiveness Analysis of Public Health Interventions to Prevent Obesity in New Zealand

    Nov 1, 2011, 00:00

  • PCN169 Differences in the Use of Innovative Anti-Cancer Drugs Among French Hospitals

    Nov 1, 2011, 00:00

  • PCV22 Geographic Variation Trends in Critical Limb Ischemia Prevalence in the United States

    Nov 1, 2011, 00:00

  • PIN72 Cost-Effectiveness of Rotavirus Immunization in Vietnam- Results and Challenges

    Nov 1, 2011, 00:00

  • PCV147 Framingham Risk Score in Health Economic Modelling- A European Perspective

    Nov 1, 2011, 00:00

  • PCV12 Differences in the Weighted Average Daily Doses of Statins in Europe and Their Potential Impact on Cardiovascular Outcomes

    Nov 1, 2011, 00:00

  • PCV122 How Patients with Chronic Stable Angina Perceive and Live with their Disease on an Everyday Basis?

    Nov 1, 2011, 00:00

  • PIN42 Methodological Decisions in Economic Evaluations of Childhood Influenza Vaccination- Findings from a Literature Review

    Nov 1, 2011, 00:00

  • PIH10 Examination of Female Balance Maintenance Ability in Major Life Stages

    Nov 1, 2011, 00:00

  • PRS62 Comparison of Generic and Disease Specific Quality of Life Measures in Chronic Obstructive Pulmonary Disease

    Nov 1, 2011, 00:00

  • PCN186 An Epidemiological Evaluation of Chemotherapy Used in the Treatment of Metastatic Prostate Cancer

    Nov 1, 2011, 00:00

  • RM3 A Comparison Between Markov Chains and System Dynamics Modeling for the Estimation of Metabolic Syndrome Costs in a Public Health Care Delivery Organization in MÉxico

    Nov 1, 2011, 00:00

  • PIN103 A Comparison of Investments for Different Prevention Programs- Respiratory Syncytial Virus Prophylaxis Versus Human Papilloma Vaccine

    Nov 1, 2011, 00:00

  • PND65 Describing and Comparing Utility from EQ-5D and SF-6D in A Huntington'S Disease Population

    Nov 1, 2011, 00:00

  • PND4 El Impacto Economico Del Tabaquismo En El Desarrollo De La Enfermedad Vascular Cerebral En Un Centro Neurologico De Tercer Nivel

    Nov 1, 2011, 00:00

  • MT3 A Bayesian Approach to Model Selection procedures within Mixed Treatment Comparison Framework

    Nov 1, 2011, 00:00

  • PUK4 COSTO-Efectividad De Intervenciones Para Insuficiencia Renal CRÓnica Terminal En MÉXICO

    Nov 1, 2011, 00:00

  • PMH67 Drug Utilisation Adaptations in Sweden After the Effexor Patent Expiry

    Nov 1, 2011, 00:00

  • PSS7 Prevalence Assessment of Diabetic Macular Edema With Visual Impairment in Spain- A Prevail Study

    Nov 1, 2011, 00:00

  • PSS11 Ranibizumab and Bevacizumab for the Treatment of Age-related Macular Degeneration- A Systematic Review and Economic Evaluation

    Nov 1, 2011, 00:00

  • PRS9 Budget Impact Analysis Of Immunotherapy in Patients with Grass Pollen Allergic Rhinitis

    Nov 1, 2011, 00:00

  • PMS3 Differentiation of Osteoporosis Treatments Action on Bone Remodeling- Principal Components Analysis of Bone Histomorphometry Parameters

    Nov 1, 2011, 00:00

  • PIN63 Cost-Effectiveness Analysis of Anti-Pneumococcal Vaccines in Panama

    Nov 1, 2011, 00:00

  • PMD27 Cost-Effectiveness Analysis of Cardiac Resynchronization Therapy in Patients with Asymptomatic to Mild Heart Failure Based on the European Cohort of the reverse Study from the Spanish Health System Perspective

    Nov 1, 2011, 00:00

  • PIN87 Hepatitis C Treatment Continuation Rates in Treatment-Naïve Genotype 1 Patients in the Brazilian Public Health Care System

    Nov 1, 2011, 00:00

  • PRM45 Importance of Collaboration with Developers in the Clarification of Concepts- A Case Study with the University of California, San Diego (UCSD) Shortness of Breath Questionnaire (SOBQ)

    Nov 1, 2011, 00:00

  • PSY1 Epidemiology And Socioeconomic Burden Of Overweight And Obesity In Argentina

    Nov 1, 2011, 00:00

  • PHP61 Modeling Pharmaceutical Costs in Primary Health Care According to Chronic Conditions

    Nov 1, 2011, 00:00

  • PCN179 Clinical Trials in Oncology in Greece

    Nov 1, 2011, 00:00

  • PHP50 Irrational Use of Injectable Form of Dexamethasone- A Warning for Health System in Iran

    Nov 1, 2011, 00:00

  • PCV87 Ticagrelor for the Treatment of Acute Coronary Syndromes (ACS)- A Dutch Analysis Based on the Plato Trial

    Nov 1, 2011, 00:00

  • PMH34 Cost-Utility of Amisulpride Compared with First Generation Antipsychotics in Treatment of Schizophrenia in Poland

    Nov 1, 2011, 00:00

  • PMS12 A Budget Impact Model for the Use of Abatacept as a First Biologic Treatment for Rheumatoid Arthritis in Italy

    Nov 1, 2011, 00:00

  • PSS3 Incidence and Characteristics of Patients with Macular Edema Secondary to Retinal Vein Occlusion in A Representative Canadian Cohort

    Nov 1, 2011, 00:00

  • PIN60 Cost-Effectiveness of Telbivudine in First Line Treatment of Hbeag-Positive Patients with Chronic Hepatitis B (CHB) in the Turkish Health Care Setting

    Nov 1, 2011, 00:00

  • PCV35 Safety and Tolerability of Bisoprolol Compared to Atenolol in Patients with Mild to Moderate Hypertension

    Nov 1, 2011, 00:00

  • PIN22 Comparison of Two Dynamic Models Predicting Future Burden of Illness of Hepatitis C (HCV) in the EU-5 (France, Germany, Italy, Spain, UK)

    Nov 1, 2011, 00:00

  • PCV99 Utilisation of Renin –Angiotensin System Agents Involved in Treatment of Cardiovascular Diseases in Slovak Republic

    Nov 1, 2011, 00:00

  • PUK5 ANÁlisis Comparativo De Costos Del Tratamiento Para La Anemia Renal Con Metoxi POLIETILENGLICOL-Eritropoyetina Beta (MIRCERA®) VS. Eritropoyetina ALFA

    Nov 1, 2011, 00:00

  • PRS48 Cost-Utility Analysis of Varenicline vs Existing Smoking Cessation Strategies in EL Salvador

    Nov 1, 2011, 00:00

  • PMD17 Noble Metal Alloy-Coated Urethral Catheter- A Budget Impact analysis in the Veneto Region of Italy

    Nov 1, 2011, 00:00

  • PND30 Cost-Effectiveness of Early vs. Non-Early Intervention in Acute Migraine with Almotriptan in Spain

    Nov 1, 2011, 00:00

  • PMD66 Demand for Routine in office Follow-up Visits for Cardiac Implantable Electrical Devices (CIED) in Germany and the United Kingdom

    Nov 1, 2011, 00:00

  • PIH24 Intra Muscular Testosterone Undecanoate (TU) (NEBIDO®) as Testosterone Replacement Therapy (TRT) for Androgen Deficiency in the Aging Male (ADAM) and Diabetes Mellitus Type 2 (DM2) Patients- Brazilian Economic Modeling

    Nov 1, 2011, 00:00

  • PSS2 Encouraging The Efficiency Of The National Transplant PROGRAM- Estimating The Cost Of Corneal Transplant To Be Financed By Public Institutions In The Health Sector In MEXICO

    Nov 1, 2011, 00:00

  • PSS25 the Cost-Effectiveness of Ozurdex® (Dexamethasone Intravitreal Implant in Applicator) Compared With Observation for the Treatment of Macular Oedema Following Central and Branch Retinal Vein Occlusion

    Nov 1, 2011, 00:00

  • PHP106 when is Lower Level Evidence of Effectiveness Acceptable in Reimbursement Decisions?- A Decision Algorithm to Guide Policy Makers

    Nov 1, 2011, 00:00

  • PMD55 Resource Utilisation related to Urinary Tract infections in Swedish Self-Catheterisation Patients

    Nov 1, 2011, 00:00

  • PGI29 Quality of Life in Chronic Liver Disease

    Nov 1, 2011, 00:00

  • PMH25 Cost of Delivering Psychiatric Inpatient Care to Mental Health Patients with Psychosis and Co-Occuring Substance Use- A UK-Based Study

    Nov 1, 2011, 00:00

  • PDB40 Economic Analysis of Diabetes Treatment Goals Defined by Polish Diabetes Association- How Much Does Cost-Effective Treatment Cost?

    Nov 1, 2011, 00:00

  • PMH81 Cost-Effectiveness Analysis of Antidepressants by the IQWIG in Germany

    Nov 1, 2011, 00:00

  • CV4 Cost-Effectiveness of Implantable Cardioverter-Defibrillator in Patients With Risk Factors for Sudden Death in Argentina

    Nov 1, 2011, 00:00

  • PHP37 Cross-Continental Comparison of HTA Evolution in Emerging Markets- Brazil, India and Poland

    Nov 1, 2011, 00:00

  • VI2 A Novel Approach to analysing Value Driver Importance Across Multiple Target Product Profiles

    Nov 1, 2011, 00:00

  • PHP46 PrÁctica Clínica Institucional En El Tratamiento De La Diabetes Mellitus Tipo 2 En MÉxico

    Nov 1, 2011, 00:00

  • PHP55 A Review of the Nice Appeals Process

    Nov 1, 2011, 00:00

  • PCV77 Economic Evaluation of Dabigatran Etexilate 150dib for the Stroke Prevention in Atrial Fibrillation in Gree A Cost –Effectiveness Analysis under the Greek NHS Setting

    Nov 1, 2011, 00:00

  • PSY45 Impact of Lupus on Career Choices and Work productivity in Five European Countries- Results from the Lupus European Online (Leo) Survey

    Nov 1, 2011, 00:00

  • PIN77 Cost Effectiveness of De-Escalation from Micafungin in the Treatment of Patients with Systemic Candida Infections Compared to Traditional Escalation from Fluconazole

    Nov 1, 2011, 00:00

  • PCN164 Does Different Availability of Oncology Care is Responsible for Differences in Cancer-related Mortality Rates Among the Provinces of Poland?

    Nov 1, 2011, 00:00

  • PCN80 Comparative Analysis of Cost-Effectiveness Bevacizumab + Paclitaxel Versus Using Only Versus Paclitaxel as First Line Treatment of Patients with Metastatic Breast Cancer in Mexico Public Insurance (Seguro Popular)

    Nov 1, 2011, 00:00

  • PIN58 Cost-Effectiveness Analysis of Pneumococcal 13-Valente Conjugate Vaccine Versus Pneumococcal 10-Valente Conjugate Vaccine in the Pediatric Immunization Routine, from the São Paulo State Public Health Care System (Brazil)

    Nov 1, 2011, 00:00

  • PCV102 Evaluation of the Measurement Properties of the Antihypertensive Adherence Survey

    Nov 1, 2011, 00:00

  • PCN156 A Survey Examining Treatment Patterns of Melanoma in Australia

    Nov 1, 2011, 00:00

  • PDB24 Budget Impact Analysis of the Use of Aspart Insulin During Hospitalization of Patients with Hyperglycaemia in Italy

    Nov 1, 2011, 00:00

  • PMH64 Diabetic Care and Risk of Acute Complications of Type II Diabetics with Schizophrenia- A Three-Year Follow-up of Hypoglycemic Therapy

    Nov 1, 2011, 00:00

  • PMD3 Biochemical Markers for the Identification of Intracranial Injury Following Minor Head injury- A Systematic Review and Meta-Analysis

    Nov 1, 2011, 00:00

  • PSY5 A Systematic Review of Tapentadol in Chronic Moderate to Severe Pain

    Nov 1, 2011, 00:00

  • PRS46 Effectiveness and Cost-Utility Estimates of Tiotropium Treatment and Pulmonary Rehabilitation Programs in French Patients with Chronic Obstructive Pulomonary Disease

    Nov 1, 2011, 00:00

  • PDB52 Adherence with Oral Medications for Diabetes Among Brazilian Patients- A Systematic Review of National Literature

    Nov 1, 2011, 00:00

  • PCN83 Cost-Effectiveness Analysis of Combination Therapies Including Class II Anticancer Drug for Advanced or Metastatic Gastric Cancer

    Nov 1, 2011, 00:00

  • PDB70 LOW-Dose Pioglitazone Utilisation in Patients with Type 2 Diabetes Mellitus in the United Kingdom

    Nov 1, 2011, 00:00

  • HT3 Understanding the Complexity of HTA Networks

    Nov 1, 2011, 00:00

  • PCN96 Costs of Adjuvant Chemotherapy with Oxaliplatin in Stage III Colon Cancer- Comparing the Three Schemes Standards- FOLFOX-4, FLOX and XELOX

    Nov 1, 2011, 00:00

  • PCV137 The Impact of Dementia on Care Patterns After Discharge for Acute Coronary Syndromes Under National Health Insurance System

    Nov 1, 2011, 00:00

  • PND25 Use of Drug Reimbursement as Markers of Disease for Epidemiological and Direct Cost analysis- The Case of Epilepsy in France

    Nov 1, 2011, 00:00

  • PCV70 Cost Effectiveness of Ticagrelor in the Treatment of Acute Coronary Syndrome in Germany

    Nov 1, 2011, 00:00

  • PSS23 Pharmacoeconomic Analyses of Partially Hydrolyzed Infant Formulas in Prevention of Atopic Dermatitis- Comparative Results From 5 European Countries

    Nov 1, 2011, 00:00

  • PRM37 Assessing the Health Status of Roma Population by Using SF-36 Health Survey- Evidence from Greece

    Nov 1, 2011, 00:00

  • HS1 Interchangeability Between Pneumococcal Conjugate Vaccines and Schemes

    Nov 1, 2011, 00:00

  • PMS51 A Cost Utility Analysis of Anti-TNF Agents for the Treatment of Rheumatoid Arthritis

    Nov 1, 2011, 00:00

  • PCV71 Sponsorship and Pharmacoeconomic Conclusions of Studies on Statin Use for Cardiovascular Prevention- A Systematic Analysis

    Nov 1, 2011, 00:00

  • PND2 Cost Offsets and Gains in Health Effects in the Treatment of Relapsing–Remitting Multiple Sclerosis with Laquinimod- An Analysis Based on the Allegro Trial

    Nov 1, 2011, 00:00

  • PCN54 Hospital Costs Related to Hepatitis C Virus Infection- First Analysis of the French Hospital National Data Base

    Nov 1, 2011, 00:00

  • PHP43 Introduction of a Prescription Charge on the Community Drug Scheme in Ireland – What Impact Has It Had on Drug Utilisation?

    Nov 1, 2011, 00:00

  • PMD33 Economic Evaluation of Two Wound Dressings for Children with Partial-Thickness Scalds from the Public Payer Perspective

    Nov 1, 2011, 00:00

  • PRM42 Valuation of HR-QoL Utilities by the EQ-5D in a Group of Chronically Ill Patients

    Nov 1, 2011, 00:00

  • PSY20 The Annual Direct Medical Cost of Systemic Lupus Erythematosus (Sle) Patients and Costs Drivers (Lucie Study)- French Results

    Nov 1, 2011, 00:00

  • PND60 An Examination of Medication Treatment Patterns Among Patients with Parksinson'S Disease Who Utilize Rasagiline or Selegiline

    Nov 1, 2011, 00:00

  • PGI15 The Cost and Quality of Life of Hepatitis C in the Netherlands

    Nov 1, 2011, 00:00

  • PMD77 Components of Health Technology Assessment for Radiology in Chile

    Nov 1, 2011, 00:00

  • PIH25 Cost-Effectiveness of Interventions Against Childhood Obesity

    Nov 1, 2011, 00:00

  • PCN121 Challenges in Conducting Pharmacoeconomic Analyses in Central and Eastern Europe – Case Study on Breast Cancer

    Nov 1, 2011, 00:00

  • PDB7 Cost-Effectiveness of Saxagliptin Treatment in Three Latin American Countries

    Nov 1, 2011, 00:00

  • PGI3 AdaptaciÓn De Un ANÁlisis De Costo-Efectividad Del Entecavir vs InterferÓn Pegilado Alfa a Venezuela

    Nov 1, 2011, 00:00

  • PIN15 Trends in Varicella-Zoster Incidence in the Netherlands Boosting Effect Within Households

    Nov 1, 2011, 00:00

  • PIH22 Cost Effectiveness of an infant Pneumococcal Conjugate Vaccine program in China

    Nov 1, 2011, 00:00

  • PIN36 Surgical Site Infection Incidence and Burden Assessment Using Multi-Institutional Real-World Data

    Nov 1, 2011, 00:00

  • PIN67 Cost-Effectiveness Analysis of Peginterferon Alfa-2A (40KD) in HBEAG-Negative Chronic Hepatitis B in Poland

    Nov 1, 2011, 00:00

  • PIN70 Modelling the Epidemiological Impact of Rotavirus Vaccination to Assess its Cost-Effectiveness in England and Wales

    Nov 1, 2011, 00:00

  • PCN170 Direct Costs of Head and Neck Cancer in the US- An Analysis Using 2008 Medical Expenditure Panel Survey (MEPS) Data

    Nov 1, 2011, 00:00

  • PIH38 Self Reported Health Status and Quality of Life Among Coastal Rural Population in South India

    Nov 1, 2011, 00:00

  • PCN130 Utility Weights for Skeletal Related Events in Castration Resistant Prostate Cancer

    Nov 1, 2011, 00:00

  • PCV40 Budget Impact Model After the Introduction of Vernakalant in Spain

    Nov 1, 2011, 00:00

  • PCV39 Heparin-Induced Thrombocytopenia Type II in Times of Demographic Changes – Epidemiological and Economic Aspects in Germany

    Nov 1, 2011, 00:00

  • PMH49 Development and Content Validity of a Patient Reported Outcomes Measure to Assess Symptoms of Major Depressive Disorder (MDD)

    Nov 1, 2011, 00:00

  • PIH8 Impact Assessment of Sport- Recreation Training

    Nov 1, 2011, 00:00

  • NI2 The Impact of Nice Guidance on the Diffusion of Medical Devices

    Nov 1, 2011, 00:00

  • PND56 Quality of Life Assessments in Adults with Attention Deficit/Hyperactivity Disorder - A Systematic Review

    Nov 1, 2011, 00:00

  • PRM38 Estimating SF-6D Health State Utility Values for Comorid Health Conditions

    Nov 1, 2011, 00:00

  • PRM59 Estimating the Confidence Interval for the Cost-Effectiveness Ratio from A Family of Regressions on Net Monetary Benefit

    Nov 1, 2011, 00:00

  • PSY56 Effect of Worksite Weight Management Program on Workers Productivity

    Nov 1, 2011, 00:00

  • PMD65 Systematic Review of Studies of the Efficiency of Negative Pressure therapy for Complex Foot Wounds in Diabetic Patients

    Nov 1, 2011, 00:00

  • PHP35 Perceptions, Knowledge and Gaps about HTA and Health Economics by the Braziian Market Stakeholders- Ispor Brazil Qualitative Research

    Nov 1, 2011, 00:00

  • PND47 The Huntington Clinical Self-Reported Instrument (H-CSRI)- Validation in Germany, Poland and USA

    Nov 1, 2011, 00:00

  • PMS10 Evaluation the Risk Factors of Second Hip Fractures in the Elderly

    Nov 1, 2011, 00:00

  • PCN175 Reimbursement of Anticancer Drugs in Canada- What Can We Learn from the Nice New Appraisal Process for Life-Extending End-of-Life Treatments?

    Nov 1, 2011, 00:00

  • PMS17 The Effect of Biological Treatment on Work Productivity and Productivity Costs of Rheumatoid Arthritis Patients

    Nov 1, 2011, 00:00

  • PCN189 The Use of Parametric Survival Analysis to Predict Progression Free and Overall Survival of Newly Diagnosed Chronic Myeloid Leukemia (CML) Patients

    Nov 1, 2011, 00:00

  • PHP28 Drugs for Rare Diseases- Influence of Oprhan Designation Status on Price

    Nov 1, 2011, 00:00

  • PHP14 Multiple Indication Pricing, Reimbursement and Funding Dynamics- The Case of Orphan Indications

    Nov 1, 2011, 00:00

  • PSS45 Treatment Patterns, Treatment Satisfaction, Disease Severity and Quality of Life in Patients with Psoriasis in Denmark, Finland, and Sweden

    Nov 1, 2011, 00:00

  • PCN21 Systematic Review of Skeletal Related Events in Prostate Cancer

    Nov 1, 2011, 00:00

  • PRS10 A Comparative Health Economic Evaluation of Two Treatments for Grass Pollen Induced Allergic Rhinoconjunctivitis

    Nov 1, 2011, 00:00

  • PDB46 Cost-Effectiveness of Angiotensin Converting Enzyme Inhibitors for the Prevention of Diabetic Nephropathy in the Netherlands - A Markov Model

    Nov 1, 2011, 00:00

  • PCN84 Population Vaccination Program for Human Papillomavirus in Spanish Girls- An Efficiency Study

    Nov 1, 2011, 00:00

  • PHP92 Lack of Clinical Efficacy as a Main Reason for Ahtapol Negative Recommendations for Orphan Oncology Drugs

    Nov 1, 2011, 00:00

  • PCV31 Cerebral Hemorrhage and Transient Ischemic Attack Affected by Meteorological Factors

    Nov 1, 2011, 00:00

  • PIN10 Clinical and Economic Burden of Hospital Onset Health Care Facility Acquired Clostridium Difficile Infection (HO-HCFA-CDI) in Europe- A Systematic Review

    Nov 1, 2011, 00:00

  • PCV108 Deriving Utility Values from the General Population for Dronedarone in the Treatment of Atrial Fibrillation

    Nov 1, 2011, 00:00

  • PCV86 Long-Term Cost-Effectiveness Analysis of Ticagrelor in Patients with Acute Coronary Syndrome (ACS) from A Mexican Public and Private Health Care Perspective Based on Data from the Plato Trial

    Nov 1, 2011, 00:00

  • PCN146 Good Prognosis, Good Quality of Life? – Longitudinal Assessment of Quality of Life in Thyroid Cancer Patients

    Nov 1, 2011, 00:00

  • PSY40 Eq-5D Utilities in Patients with Chronic Pain Due to Osteoarthritis of the Knee or Low Back Pain Treated with Tapentadol and Oxycodone

    Nov 1, 2011, 00:00

  • PIN28 Consumption Pattern and the Cost Analysis of Parenteral Antibiotics in A

    Nov 1, 2011, 00:00

  • PHP30 Biosimilars in the European Market

    Nov 1, 2011, 00:00

  • PDB13 A Prospective Registry to Identify Patients' Characteristics Associated with Achieving Target Metabolic Control After Three Months Treatment with Insulin Glulisine in Type 1 And 2 Diabetes Mellitus Patients Previously Uncontrolled on ...

    Nov 1, 2011, 00:00

  • PHP133 Levels of Population Risk Stratification Based on the Cost of Care in Patients with Chronic Diseases

    Nov 1, 2011, 00:00

  • PHP131 How Can Pharma Industry Prepare Itself for the Changing Pricing and Reimbursement Landscape of Orphan Drugs in EU?

    Nov 1, 2011, 00:00

  • PHP56 The Emergent Role of the Specialist Pharmacist as an Important Stakeholder in Market Access

    Nov 1, 2011, 00:00

  • PDB41 The Cost-Effectiveness of Getting to Glucose, Blood Pressure, and Lipid Goals in Patients Newly Diagnosed with Type 2 Diabetes Mellitus (T2DM) and Younger Than Fifty in Sweden

    Nov 1, 2011, 00:00

  • PHP34 Necesidades De información Y formación Sobre Farmacoeconomia E Investigación De Resultados Para Profesionales Y Estudiantes De Farmacia Del Oriente Venezolano

    Nov 1, 2011, 00:00

  • PMH23 The Economic Burden of Mental Ill Health in the Workpla A Costing Approach for Brazilian Employers

    Nov 1, 2011, 00:00

  • PSY44 Association of the Obesity and Weight-Loss Quality-of-Life Score With Patient Demographics and Measures of Obesity

    Nov 1, 2011, 00:00

  • PCV129 Discrepancies Between Defined Daily Doses and Actual Prescription Patterns in the Polish Setting- the ACE Inhibitors Example

    Nov 1, 2011, 00:00

  • PIN32 Economic Burden of Non-CF Bronchiectasis Enrolled in a US Managed Care Plan

    Nov 1, 2011, 00:00

  • PRS36 The Cost-Effectiveness of Step Down from High Dose ICS/Laba Combination Therapy in Asthma in the UK Setting

    Nov 1, 2011, 00:00

  • PCV148 Multiple Propensity Score Analysis to Estimate Treatment Effects in Patients with Heart Failure

    Nov 1, 2011, 00:00

  • PGI9 Impact of Dysphagia on U.S. Hospital Charges in Patients with Comorbid Conditions

    Nov 1, 2011, 00:00

  • PIH62 Comparative Pricing and Reimbursement Analysis in Four East European Countries

    Nov 1, 2011, 00:00

  • PIN94 Assessment of Health Related Quality of Life (HRQOL) in Hepatitis- B Patients

    Nov 1, 2011, 00:00

  • PSY7 Budget Impact Analysis of Bendamustine in the Treatment of Multiple Myeloma in Spain

    Nov 1, 2011, 00:00

  • PCN197 Health Related Quality of Life in Long Term Survivors of Lymphoma- A Population Based Study

    Nov 1, 2011, 00:00

  • PMS56 Subjective Health Expectations of Rheumatoid Arthritis Patients Starting Biological Therapy

    Nov 1, 2011, 00:00

  • PRS3 Costos De atencion Medica De La Enfermedad Pulmonar Obstructiva Cronica atribuibles Al Tabaco

    Nov 1, 2011, 00:00

  • PCN147 Health-Related Quality of Life in Head and Neck Cancer Patients - Comparison with General Population Norms

    Nov 1, 2011, 00:00

  • PHP22 Are Hospital Medicines Prices Influenced by Discounts and Rebates?

    Nov 1, 2011, 00:00

  • PIN8 A Decision Tree Model Comparing Clinical Outcomes of Treatment with Telbivudine with or without “Tenofovir Add-on as Needed” and Lamivudine with or without “Tenofovir Add-on as Needed” in the Treatment of Chronic Hepatitis B Infection ...

    Nov 1, 2011, 00:00

  • PHP78 Convergent Tendencies in Budget Impact Analysis Across Europe and Beyond- Germany - Don'T Lose out on the “Zeitgeist”!

    Nov 1, 2011, 00:00

  • PSY3 Use Of A Discrete Event Simulation Model To Estimate Long Term Economic Outcomes Of Bariatric Surgery In Morbidly-Obese, Type-2 Diabetic Patients In Mexico

    Nov 1, 2011, 00:00

  • PMD81 Decision Analytic Models Used in Estimating the Cost-Effectiveness of Drug-Eluting Stents versus Bare-Metal Stents

    Nov 1, 2011, 00:00

  • HS3 The Economic Burden of Road Traffic Injuries on Health System and Society in Belize

    Nov 1, 2011, 00:00

  • PMS71 A Population Based Assessment of Osteoporosis Prevalence and Treatment in Primary Health Care in Madrid (Spain)

    Nov 1, 2011, 00:00

  • PHP93 Regional Differences among Methadone Maintenance Programs in Spain

    Nov 1, 2011, 00:00

  • MA2 Mapping Fact-P to Country Specific Patient Health Status Measured by EQ-5D in Metastatic Castrate Resistant Prostate Cancer Patients

    Nov 1, 2011, 00:00

  • PMH75 Physician Differences between Italy and Germany- The Treatment of Opioid Dependence with Substitution Therapy

    Nov 1, 2011, 00:00

  • PMH1 Comparing The Effectiveness Of Paliperidone Palmitate Versus Olanzapine Pamoate For Relapse Prevention In Schizophrenia- Post Hoc Indirect Analysis Using Published Placebo-Controlled Studies

    Nov 1, 2011, 00:00

  • PCV73 Cost Effectiveness of Speech and Language Therapy Following Stroke

    Nov 1, 2011, 00:00

  • PRM47 Review of Clinician and Observer Reported Outcomes Measures Translation Methodologies

    Nov 1, 2011, 00:00

  • PDB65 Unmet Need and Drug Management Challeneges in Elderly Type 2 Diabetes Medicare Part D Population

    Nov 1, 2011, 00:00

  • PCN25 Budget Impact Analysis of Switching to Digital Mammography in A Breast Cancer Population-Based Screening Program

    Nov 1, 2011, 00:00

  • PIH28 Economic Evaluation of Pneumococcal Conjugated Vaccines for Argentina

    Nov 1, 2011, 00:00

  • PCV89 Cost-Effectiveness Analysis of Rosuvastatin Versus Generic Atorvastatin in Patients at High Cardiovascular Risk in Spain

    Nov 1, 2011, 00:00

  • PSY16 Cost and Quality of Life Benefits of Faster Bleed Resolution with an Rfviia Analogue- a Mathematical Simulation Study for the German Population

    Nov 1, 2011, 00:00

  • PIN30 Cost Analysis of Voriconazole Versus Itraconazole for Prophylaxis of Invasive Fungal Infection (IFI) in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in Canada, France, Germany, and the United States

    Nov 1, 2011, 00:00

  • PHP162 Impact of AMNOG on Pharmaceutical Pricing Trends in Germany

    Nov 1, 2011, 00:00

  • PCV93 the Polypill in the Primary Prevention of Cardiovascular Disease- Cost-Effectiveness in the Dutch Population

    Nov 1, 2011, 00:00

  • CN2 Cancer De Pulmon Y Tabaco, Analisis Del Costo De Atencion Medica

    Nov 1, 2011, 00:00

  • PIN80 Cost-Effectiveness of Vaccinating Children Aged 2-17 Years with Intranasal Live Attenuated Influenza Vaccine (LAIV) in Germany

    Nov 1, 2011, 00:00

  • PSS6 Epidemiology, Disease Burden, Symptomatology, Treatment Pattern, and Quality of Life in Macular Degeneration in Korea- Systematic Literature Review Based on Korean Evidence

    Nov 1, 2011, 00:00

  • PIN107 Tobramycin Inhaled Solution Utilization by Cystic Fibrosis Patients- An Analysis with the RAMQ Database

    Nov 1, 2011, 00:00

  • PCV116 The Impact of High Risk of Stroke Patients Diagnosed with atrial Fibrillation on Health-Related Quality of Life, and Health Care Use in 5EU

    Nov 1, 2011, 00:00

  • PIH5 Respiratory Syncytial Virus (RSV) Prophylaxis in Special Populations

    Nov 1, 2011, 00:00

  • PDB45 Cost-Effectiveness of Transferring Type 2 Diabetic Patients from Neutral Protamine Hagedorn (NPH) to Detemir in Portugal Settings

    Nov 1, 2011, 00:00

  • PMS75 Explanatory Factors for the Rheumatoid Arthritis Patients' Access to Biological Agents in 15 European Countries

    Nov 1, 2011, 00:00

  • PGI2 The Relationship Between Acute and Chronic Acetaminophen Exposure and Liver Toxicity

    Nov 1, 2011, 00:00

  • PRM35 Agreement Between Patients' Self-Report and Physicians' Prescriptions on Drugs and Vaccine Exposure- The International PGRX Database Experience

    Nov 1, 2011, 00:00

  • PRM6 Validating an Alternative Weighting Algorithm of the Charlson Comorbidity Index (CCI) for Risk Adjustment in Previously Hospitalized Patients

    Nov 1, 2011, 00:00

  • PHP23 La Aceptacion De Las Vacunas En Los programas Nacionales De inmunizacion En Latina America- Un Estudio Comparativo

    Nov 1, 2011, 00:00

  • PHP100 Did Iqwig‘S Drug Appraisals in Connection with G-BA‘S Directives Change Prescribing Behavior of German Physicians?

    Nov 1, 2011, 00:00

  • PIN17 Modelling Budget Impact (BI) of Vaccinating At-Risk Adults and the Elderly with 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) Compared to 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in Germany

    Nov 1, 2011, 00:00

  • PHP46 Market Uptake of Orphan Drugs – A European Analysis

    Nov 1, 2011, 00:00

  • PHP44 Characteristics of Patients Treated for Fibromyalgia in Puerto Rico and the United States- Baseline Findings of the Reflections Study (Real World Examination of Fibromyalgia- Longitudinal Evaluation of Costs and Treatments)

    Nov 1, 2011, 00:00

  • PCV144 Stroke Prevention in Patients with Atrial Fibrillation- Inappropriate Anticoagulation and Poor INR Control

    Nov 1, 2011, 00:00

  • PCV69 Economic Evaluation of Primary Prevention of Cardiovascular Diseases in Mild Hypertension- A Scenario Analysis for the Netherlands

    Nov 1, 2011, 00:00

  • PHP4 Significant Decrease in the Hungarian Health Insurance Pharmaceutical Budget Between 2006-2009

    Nov 1, 2011, 00:00

  • PMD56 A Systematic Literature review on the Clinical and Economic outcomes attributable to the Use of Hemostatic Matrix during Tonsillectomy and Adenoidectomy

    Nov 1, 2011, 00:00

  • PDB10 Economic Evaluation of Duloxetine as First-Line Treatment for Painful Diabetic peripheral Neuropathy in Mexico

    Nov 1, 2011, 00:00

  • PHP40 Perception Study of Undergraduates Towards Medicines – A Survey

    Nov 1, 2011, 00:00

  • PCN87 The Cost Effectiveness of Cetuximab (Erbitux) in the Third Line Treatment of Metastatic Colorectal Cancer in the UK

    Nov 1, 2011, 00:00

  • QA4 Cost-Utility of Sacral Neuromodulation Versus Augmentation Cystoplasty for Treatment of Refractory Urge Incontinence in México

    Nov 1, 2011, 00:00

  • PDB53 Diabetes Medication Adherence and Glycemic Control in Penang, Malaysia

    Nov 1, 2011, 00:00

  • PCV67 Health-Economic Impact of the Hungarian Salt Intake Reduction Program

    Nov 1, 2011, 00:00

  • UT3 The Validity Of The EQ-5D, SF-6D, SF-36 and SF-12 In Mental Health Conditions- A Systematic Review

    Nov 1, 2011, 00:00

  • PCN133 Measuring Patients' Expectation and Satisfaction With Integrative Cancer Therapy

    Nov 1, 2011, 00:00

  • PCN154 Discussing the Introduction of National Screening Programs in Gree A Delphi Study

    Nov 1, 2011, 00:00

  • PCV8 Effect of SIADH on Patient Outcomes and Health Care Resource Utilization in Hospitalized Patients

    Nov 1, 2011, 00:00

  • PIN13 Epidemiology of Staphylococcus Aureus Infections in Children- A Literature Review of the Last 10 Years

    Nov 1, 2011, 00:00

  • PMH4 Extent of Attaining and Maintaining Symptom Remission by Antipsychotic Medication in the Treatment of Chronic Schizophrenia- Evidence from the Catie Study

    Nov 1, 2011, 00:00

  • PDB3 Hypoglycaemia-Related Emergency Department Visits and Hypoglycaemia-Related Hospitalizations Among News Users of Antidiabetes Treatments

    Nov 1, 2011, 00:00

  • PCV50 Hospital Costs Associated with Atrial Fibrillation in Canada

    Nov 1, 2011, 00:00

  • PCV9 Costo–efectividad De Los Ácidos Grasos Omega 3 Como Coadyuvante De La Simvastatina En El Tratamiento De La Hipertrigliceridemia

    Nov 1, 2011, 00:00

  • PHP49 The Pharmacist'S Perception of the Splitting Extended Release and Enteric-Coated Formulation Drugs

    Nov 1, 2011, 00:00

  • PMD8 Systematic Review of the Impact Different Metal Femoral Stems (MFSS) Have on Patient outcomes in total Hip replacement (THR) Due to Osteoarthritis (OA)

    Nov 1, 2011, 00:00

  • PDB4 Gastos Com Medicamentos E Características De indivÍduos Com HipertensÃo E Diabetes Mellitus, Em MunicÍpios Da rede FarmÁcia De Minas - Minas Gerais, Brasil

    Nov 1, 2011, 00:00

  • PCV95 Economic Analysis of Interventions to Improve Control of Blood Pressure in Nigerian Hospitals

    Nov 1, 2011, 00:00

  • PCV10 Anti-Glycemic Medication Treatment Patterns Among Type II Diabetes Mellitus Patients Initiating Lipid-Altering Regimens

    Nov 1, 2011, 00:00

  • PRM21 Validating a Multi-Criteria Decision Analysis (MCDA) Framework for Health Care Decision Making

    Nov 1, 2011, 00:00

  • PMD61 The Effects of Subjective Insomnia Pattern on the quality of Life of the Climacteric Women in Taiwan

    Nov 1, 2011, 00:00

  • PDB6 Educational Interventions in Patients with Type-2 Diabetes Improve Clinical and Metabolic Outcomes and Optimize the Use of Treatment Resources in Argentina- The Prodiacor Study

    Nov 1, 2011, 00:00

  • MO3 A Methodological Framework for Developing Models of Whole Disease Areas to Inform Resource Allocation Decisions

    Nov 1, 2011, 00:00

  • PSY32 Modeling Cost-Effectiveness of Drug Treatments for Severe Chronic Non-Cancer Pain in Portugal

    Nov 1, 2011, 00:00

  • PUK14 Trends in Rate and Cost of Hospitalizations Due to Chronic Kidney Disease (CKD) in the United States

    Nov 1, 2011, 00:00

  • PND19 Cost Of The Relapse Of Multiple Sclerosis In Spain

    Nov 1, 2011, 00:00

  • PMS20 Treatment of Patients with Moderate and Severe Psoriasis – Cost-of-Illness in the Czech Republic

    Nov 1, 2011, 00:00

  • PCN39 Burden of Brain Metastasis in an Metastatic Non-Small Cell Lung Cancer (NSCLC) Population

    Nov 1, 2011, 00:00

  • PR4 Calidad De Vida Y Victimizacion En Adolescentes Estudiantes De MÉxico

    Nov 1, 2011, 00:00

  • PHP129 Societal Preferences for Health Technology Disinvestment Policy- Views of Scottish Taxpayers – A Qualitative Study

    Nov 1, 2011, 00:00

  • PIN64 Cost-Effectiveness Analysis of Anti-Pneumococcal Vaccines in Guatemala

    Nov 1, 2011, 00:00

  • PR2 The Beauty of Mapping- Need the Mean Health-Related Quality of Life Score for a Group of Hip Patients and Don't Have EQ-5D? Just Use the Oxford Hip Score!

    Nov 1, 2011, 00:00

  • PMS14 Cost of Etanercept, Adalimumab, and Infliximab Per Treated Patient Across Adult Indications Using Real-World Data

    Nov 1, 2011, 00:00

  • PND20 A Cost-of-Illness Analysis Of Amyotrophic Lateral Sclerosis In Greece

    Nov 1, 2011, 00:00

  • PIH3 Resource Use And Associated Costs For The Treatment Of Heavy Menstrual Bleeding With Levonorgestrel Releasing Intrauterine System (LNG-IUS) Versus Hysterectomy- The Brazilian Public Healthcare System (SUS) Perspective

    Nov 1, 2011, 00:00

  • PHP121 The Role of Molecular Tests in Shaping Comparative Effectiveness Review (CER)

    Nov 1, 2011, 00:00

  • PDB77 Impact of Knowledge on Medication Adherence Among Type 2 Diabetes Patients

    Nov 1, 2011, 00:00

  • PIN37 The Cost of Managing Chronic Hepatitis C in Sweden - Medical Resource Utilisation in Different Stages of the Disease

    Nov 1, 2011, 00:00

  • PHP108 Public Health and Prevention in Europe- Is it Cost-Effective?

    Nov 1, 2011, 00:00

  • PHP31 Analisis Costo Efectividad Sectorial De 45 Intervenciones Sanitarias En Chile

    Nov 1, 2011, 00:00

  • PSY30 Cost Effectiveness of Tramadol Versus Diclophenac in Pain Management After Cesarean Delivery

    Nov 1, 2011, 00:00

  • PSS21 Treatment Patterns, Costs and Quality of Life in Patients With Plaque Psoriasis in Denmark

    Nov 1, 2011, 00:00

  • PRS7 Efficacy and Safety of Sildenafil Above 60 mg Daily in Pulmonary Arterial Hypertension Treatment - a Systematic Literature Review

    Nov 1, 2011, 00:00

  • PSU23 Rehabilitation Needs and Predictive Factors of Health-Related Quality-of-Life in Breast Cancer Patients During Two Years After Surgery - A Multicenter Prospective Study

    Nov 1, 2011, 00:00

  • PDB19 Prevalence of Diabetes Mellitus Among Patients with Vascular Complications in Poland

    Nov 1, 2011, 00:00

  • PIN12 Epidemiology, Outcomes, and Costs of Hospitalization Due to Pneumonia, Meningitis, and Septicemia in Canada from 2004 to 2010

    Nov 1, 2011, 00:00

  • PHP140 “Troica” Health Care Economics in Greece

    Nov 1, 2011, 00:00

  • PRM5 Incorporating Equity Into Developing and Implementing Evidence-Based Clinical Practice Guidelines

    Nov 1, 2011, 00:00

  • PCN155 The Challenges of Estimating Costs of Palliative Care- A Systematic Literature Review

    Nov 1, 2011, 00:00
  • «
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126 (current)
  • 127
  • 128
  • 129
  • 130
  • »